In hepatocellular carcinoma (HCC), Guo and colleagues (2023) demonstrated that the loss of 5hmC induced chemoresistance through the histone acetyltransferase P300/CBP-associated factor (PCAF)/AKT axis [141]. Here, EP300 is linked to hepatocellular carcinoma.